menu
Over 90 firms are actively involved in providing in vitro ADME testing services; of these, over 30 players claim to provide end-to-end services
ADME studies are considered to be critical in establishingthe safety and efficacy of drug candidates. Currently, there are a number ofcontract research organizations (CROs) that claim to have the necessarycapabilities to offer in vitro ADME services. Over time, such service providershave grown to become an indispensable part of the pharmaceutical /biopharmaceutical market.

ADME studies are considered to be critical in establishingthe safety and efficacy of drug candidates. Currently, there are a number ofcontract research organizations (CROs) that claim to have the necessarycapabilities to offer in vitro ADME services. Over time, such service providershave grown to become an indispensable part of the pharmaceutical /biopharmaceutical market.

 

To order this 280+ page report, which features 135+ figuresand 120+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/in-vitro-adme-testing-services-market-2019-2030/239.html

 

The USD 2.2 billion (by 2030) financial opportunitywithin the vitro ADME testing services market has been analyzed across the following segments:

 

§ Type of Molecule

§ Small Molecules

§ Biologics

 

§ Type of Service

§ Absorption Testing

§ Distribution Testing

§ Metabolism andElimination Testing

 

§ Type of Assay

§ Caco-2 PermeabilityAssay

§ PAMPA PermeabilityAssay

§ MDCK PermeabilityAssay

§ Protein Binding Assay

§ Blood Brain BarrierAssay

§ Blood to Plasma Ratio

§ Stability / ClearanceAssay

§ Enzyme InductionAssay

§ Enzyme InhibitionAssay

§ Metabolite Profilingand Screening / Identification Assay

§ Metabolite ProductionAssay

§ Reaction PhenotypingAssay

§ TransporterInteractions Assay

 

§ Target TherapeuticArea

§ Blood Disorders

§ CardiovascularDisorders

§ Gastrointestinal andDigestive Disorders

§ Hormonal Disorders

§ Infectious Diseases

§ ImmunologicalDisorders

§ Metabolic Disorders

§ Mental Disorders

§ NeurologicalDisorders

§ Oncological Disorders

§ Respiratory Disorders

§ Skin Disorders

§ Urogenital Disorders

§ Others

 

§ Type of Sponsor

§ Industry Players

§ Non-Industry Players

 

§ Key GeographicalRegions

§ North America

§ Europe

§ Asia-Pacific and Restof the World

 

The InVitro ADME Testing Services Market, 2019-2030 report features thefollowing companies, which we identified to be key players in this domain:

§ Albany MolecularResearch (AMRI)

§ Charles RiverLaboratories

§ PharmaceuticalProduct Development (PPD)

§ RTI International

§ Eurofins Scientific

§ Evotec

§ Galapagos

§ Tecan Group

§ GVK Biosciences

§ Pharmaron

§ Sai Life Sciences

§ Shanghai Medicilon

§ WuXi AppTec

 

Table of Contents

 

1. Preface

2. Executive Summary


3. Introduction

4. Guide to Outsourcing

5. Market Landscape

6. Company Profiles

7. Benchmark Analysis 

8. Mergers and Acquisitions

9. Regulatory Recommendations andGuidelines

10. Market Forecast

11. Conclusion

 

12. Executive Insights

 

13. Appendix 1: Tabulated Data

 

14. Appendix 2: List of Companies andOrganizations

 

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/in-vitro-adme-testing-services-market-2019-2030/239.html

 

Contact Details-

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com